Navigation Links
Esperanza Announces Support of H.R. 1108, Encourages Congress to Pass FDA Regulation of Tobacco
Date:5/12/2008

House Bill Gives FDA Regulatory Authority Over Tobacco

WASHINGTON, May 9 /PRNewswire-USNewswire/ -- Esperanza, the largest Hispanic faith-based organization in the country, today announces their support of H.R. 1108, "The Family Smoking Prevention and Tobacco Control Act." The legislation gives FDA regulatory authority over tobacco products.

"We encourage Congress to pass this important legislation this year. H.R. 1108 has broad bi-partisan support and could genuinely help our people," said the President of Esperanza Rev. Luis Cortes. "Within our Hispanic community lung cancer is the leading cause of cancer deaths. With 16.2 percent of Hispanic adults smoking cigarettes, a significant part of our community is at high-risk."

"With regulatory authority over tobacco, the FDA could further restrict sales of tobacco products to children, require more meaningful warnings on tobacco products, and enable consumers to access the information on all the ingredients in any given tobacco product," Cortes continued. "We urge Congress to pass this legislation this year."

The Reverend Luis Cortes, Jr. is the founder and president of Esperanza. Esperanza is the largest Hispanic Faith-Based Evangelical network in the country. With a national network of 12,000 faith and community-based agencies, Esperanza is one of the leading voices for Hispanics in America.


'/>"/>
SOURCE Esperanza
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Pregis Announces First Quarter 2008 Financial Results
2. Almost Family, Inc. Announces Exercise of Over-Allotment Option
3. Somanetics Announces Share Repurchase Program Increased by $15 Million
4. China Medicine Announces Conference Call to Discuss First Quarter 2008 Results
5. Hooper Holmes Announces First Quarter 2008 Results
6. Bradmer announces 2008 first quarter operational and financial results
7. Shengtai Pharmaceutical, Inc. Announces Conference Call to Discuss Third Quarter Results of Fiscal Year 2008
8. Team Finance LLC Announces First Quarter 2008 Results
9. PennWell Announces DDS Tech Fair
10. IRIDEX Announces First Quarter 2008 Conference Call and Release Date
11. Long Term Care Group, Inc. Announces Hiring of New CIO
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2017)... Peoria, IL (PRWEB) , ... May 22, 2017 ... ... HealthCare, is part of a larger group investing in InsightRX, an early stage ... a patient’s underlying biological and pharmacological characteristics. Greatpoint Ventures Innovation Fund ...
(Date:5/21/2017)... FL (PRWEB) , ... May 20, 2017 , ... Pot. ... it, find it, review it, and share its attributes like never before. More than ... directory to connect cannabis enthusiasts to stores, strains, products – and for the first ...
(Date:5/21/2017)... ... May 21, 2017 , ... ... longer than six months since you've seen a dentist, it's time for a ... and getting x-rays once per year. , Dental checkups are a relatively easy ...
(Date:5/19/2017)... ... May 19, 2017 , ... Springfield, Vermont-based law firm ... Titled " Ten Good Reasons To Hire An Experienced Personal Injury Attorney, " the ... an accident or injury. As the article says. if someone is injured due ...
(Date:5/19/2017)... ... 19, 2017 , ... As a groundbreaking surgeon on the frontline of prostate ... screenings. Early detection of the disease, he says, can make a world of difference. ... , stands alongside the Georgia Comprehensive Cancer Control’s (GC3) Prostate Cancer Task Force and ...
Breaking Medicine News(10 mins):
(Date:5/22/2017)...  As the specialty pharmacy industry and the ... the revolutionary shift from volume-based to value-based care, ... patient outcomes and shaping the future of the ... from clinical trials and toward data that reveals ... therapy utilization in precise patient populations. Therigy ® ...
(Date:5/18/2017)...  Bayer announced today that the latest research from ... the 53 rd Annual Meeting of the American ... in Chicago . ... liver and thyroid cancers, as well as lymphomas, and ... trial of copanlisib in patients with relapsed or refractory ...
(Date:5/15/2017)... 2017 Enterin Inc., a privately-held CNS pharmaceutical company ... compounds to treat Parkinson,s disease (PD), has enrolled the first ... 1/2a randomized, controlled, multicenter study involving patients with PD and ... patients over a 9-to-12-month period. The first stage is open ... PD. Participating sites include Denver , ...
Breaking Medicine Technology: